| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.17 | 0.003 |